In recent months there has been a surge (pun intended) of media and patient interest in energy-based devices to treat gynecologic symptoms such as vaginal laxity, pain with intercourse, vaginal atrophy, dryness, itching, urinary incontinence and other concerns related to menopause and sexual function. There are two main categories of these devices: laser technology and radiofrequency energy. The underlying principle is to promote the body’s natural collagen production process and improve cellular integrity, tone, function and lubrication.
In early research, radiofrequency energy devices appear to be better positioned to treat urinary incontinence and vaginal relaxation syndrome over lasers. After careful consideration of current options on the market, we at Partners Obstetrics and Gynecology have decided to offer the Viveve cryogen-cooled monopolar radiofrequency (CMRF) device as a non-invasive, painless, office-based treatment option for our patients.
As with anything new, it is usually not the first go to treatment but an option to try if other treatments have failed or a patient is not a candidate. In fact, in July of 2018, the FDA released a statement reiterating the need for research and randomized clinical trials to gather information and allow these treatments to gain widespread acceptance. The American College of Obstetricians and Gynecologists as well as the North American Menopause Society have both continued to support research for this.
At Partners Obstetrics and Gynecology it is our mission to advocate for female sexual health and wellness through and individualized approach with each patient but at the same time offer responsible use of innovative technology and evidence based treatment options for optimal success in your health care.